Background: CYP19A1 encodes the aromatase which catalyzes the final reaction of estrogen biosynthesis. The bovine genome also contains a non-coding copy of CYP19A1, the transcribed pseudogene CYP19P1. Whereas CYP19A1 is transcribed in all estrogen-producing tissues, mainly in the placenta and gonads, the CYP19P1 transcript so far was detected in the placenta. Strikingly, one sequence segment of both transcripts exhibits an exceptional high identity of 98%, which implies selective pressure and suggests some kind of function. Only recently, indeed, coding-independent functions of several transcribed pseudogenes were reported. Therefore, we analyzed CYP19P1 and CYP19A1 transcripts with the aim to detect clues for gene-pseudogene interference. Findings: The CYP19P1 transcript was first examined in silico for the presence of microRNA coding sequences and microRNA targets. Further, to identify tissues where CYP19P1 and CYP19A1 transcripts are co-expressed, as a pre-requisite for transcript interference, expression profiling was performed in a variety of bovine tissues. Our in silico analyses did neither reveal potential microRNA coding sequences, nor microRNA targets. Co-expression of the CYP19 loci was demonstrated in placental cotyledons and granulosa cells of dominant follicles. However, in granulosa cells of dominant follicles the concentration of CYP19P1 mRNA was very low compared to CYP19A1 mRNA. Conclusions: CYP19P1 and CYP19A1 transcripts might interfere in placental cotyledons. However, in granulosa cells of dominant follicles relevant interference between gene and pseudogene transcripts is unlikely to occur because of the very low CYP19P1/CYP19A1 transcript ratio.
Findings
Background CYP19A1 encodes the aromatase which catalyzes the conversion of androgens to estrogens. During an earlier screening of a bovine placental cDNA library for CYP19A1 clones, we also isolated cDNA clones of a homologous pseudogene, CYP19P1 [1, 2] . Gene and pseudogene transcripts exhibit major differences due to the loss of several exons in the CYP19P1 transcript. Furthermore, numerous mutations in the pseudogene sequence produced multiple translational stop codons in all reading frames and thereby abrogated its protein-coding function. Strikingly, however, mutations are unevenly distributed. A sequence segment of 177 bp corresponding to exon 5 of CYP19A1 is highly conserved, showing 98% identity, compared to 89% sequence identity in general [2] . Both CYP19 loci are located on the same strand of chromosome 10, being separated by 20 kb of genomic DNA [3, 4] .
Pseudogenes for long were considered as defunct copies of functional genes. However, recent evidence suggests that some pseudogenes might exert coding-independent functions [5, 6] . Interestingly, gene-pseudogene interference was demonstrated by selective knock-down of the ABCC6P1 pseudogene, which led to a decreased transcription of its ABCC6 parent gene [7] . This recent evidence prompted us to take up again our analysis of the CYP19P1 pseudogene with the aim to detect clues of gene-pseudogene interference. To this end, transcripts were searched in silico for microRNA-coding sequences and microRNA targets. Further, expression profiles of CYP19A1 and CYP19P1 were analyzed in a variety of bovine tissues.
Materials and methods
Samples from placentas, ovarian granulosa cells, fetal ovaries, endometria, adrenal glands and livers were collected from slaughtered cows in a local abattoir. Tissue samples were stored in RNAlater (Qiagen, Hilden, Germany) at -20°C. Granulosa cells were frozen in liquid nitrogen and stored at -80°C. Placental cotyledons and caruncles were separated manually. Despite careful separation, caruncle samples might contain traces of cotyledonary cells. Ovarian dominant and pre-ovulatory follicles collected before and after the LH-surge, respectively, were identified as described in [8] . Follicles were punctured with 18G needles and granulosa cells were aspirated. Total RNA was prepared using the NucleoSpin RNA II Kit (Macherey-Nagel, Düren, Germany), according to the supplier´s protocol. This procedure included oncolumn DNaseI digestion to remove traces of DNA. RNA was quantified in a NanoDrop 1000 spectrophotometer (PeQLab, Erlangen, Germany). RNA integrity was confirmed by denaturing agarose gel electrophoresis.
The abundance of CYP19P1 and CYP19A1 transcripts was measured by quantitative reverse transcription PCR (qPCR). For normalization purposes, the RPLP0 transcript encoding a ribosomal large subunit protein was also measured. RNA (100 ng) was reverse transcribed in a 25 μl reaction volume using a mixture of random hexameric and oligo dT primers (Roche, Mannheim, Germany) and M-MLV reverse transcriptase (Promega, Mannheim, Germany). cDNA was purified with the High Pure PCR Product Purification Kit (Roche). For subsequent real time PCR, cDNA was amplified in a 12 μl reaction volume with the SensiFast SYBR No-ROX Kit (Bioline, Luckenwalde, Germany) using following primer pairs: CYP19P1_for, 5´-TCATTACAACGCATCCCCAGGTT GA-3´/CYP19P1_rev, 5´-CTAGGTCCATGACGGGCT GGTATCA-3´, CYP19A1_for, 5´-GGATCGGCAGTG CCTGCAATTACTA-3´/CYP19A1_rev, 5´-ATGCCGA TGAACTGCAACCCAAGTT-3´and RPLP0_for, 5´-TGGTTACCCAACCGTCGCATCTGTA-3´/RPLP0_rev, 5´-CACAAAGGCAGATGGATCAGCCAAG-3´(Sigma-Aldrich, Taufkirchen, Germany). The primer pairs were designed to flank intronic sequences of genomic DNA. The expected products from cDNA were 156, 174 and 140 bp in length, respectively. The amplification and quantification of resulting PCR products were performed in a Light-Cycler 480 instrument (Roche) under following cycling conditions: Pre-incubation at 95°C for 5 min, followed by 40 cycles of denaturation at 95°C for 20 s, annealing at 60°C for 15 s, and extension at 72°C for 15 s, and single point fluorescence acquisition at 75°C for 10 s to avoid quantifying primer artifacts. The generation of only the expected products was confirmed by melting curve analysis and agarose gel electrophoresis, which did not reveal PCR products from genomic DNA ( Figure 1B) . External standard curves were generated by co-amplification of various dilutions of cloned PCR products (5 × 10 −12 to 5 × 10 −16 g DNA/reaction) with the corresponding primer pairs. The statistical analyses were performed with the Sigma Plot 12.0 Analysis System (Jandel Scientific, San Raffael, CA, USA).
Results and discussion
The remarkably high conservation of CYP19P1 in the exon 5-homologous sequence segment (henceforth referred to CYP19P1 P 83% CYP19A1 Z69242 99% E In P2 E2 In as P1-exon 5) implies selective pressure. Hence, it might well be that the pseudogene exerts a coding-independent biological activity via the P1-exon 5. Because pseudogenederived small interfering RNAs were shown to regulate gene expression in mouse oocytes [9] , we examined if also the CYP19P1 transcript encodes microRNAs. We performed in silico analyses of the P1-exon 5 using the free software RNAfold [10] to detect putative stable pre-microRNA hairpins. However, no such structures were predicted by the program. The cellular abundance of the tumor suppressor gene PTEN transcript was found to be regulated by the transcript of the highly homologous PTENP1 pseudogene via competition for micro-RNA binding [11] . To evaluate if the CYP19 gene pair could also interfere this way, we searched the P1-exon 5 for microRNA target sites using the MIRANDA software [12] . However, probable targets of known microRNAs were not found. Other pseudogenes are transcribed in an antisense orientation and lead to silencing of their parent genes by translational interference [5] . However, this mode of action can not apply to CYP19P1 and CYP19A1 which are both encoded by the same strand of chromosome 10 [4] and hence are transcribed in the same orientation. For possible interference, CYP19P1 and CYP19A1 transcripts need to be co-expressed. So far, expression of CYP19P1 has not been studied in bovine tissues other than placenta. To evaluate co-expression as a prerequisite for transcript interference, we performed qPCR to measure the abundance of CYP19P1 and CYP19A1 transcripts in a variety of bovine tissues. These included granulosa cells from dominant follicles and placental cotyledons, which were known to express CYP19A1 [13] . Further, granulosa cells from pre-ovulatory follicles, fetal ovaries, placental caruncles, endometrium, adrenal gland and liver were also analyzed, to find out whether the tissue-specificity of CYP19A1 expression is retained in CYP19P1. The results of the qPCR experiments are presented in Figure 1A . As expected, cotyledons and granulosa cells from dominant follicles expressed considerable amounts of the CYP19A1 transcript. In contrast, the CYP19A1 transcript concentration was low or undetectable in the remaining tissue samples. Likewise, the CYP19P1 transcript was found in cotyledons and granulosa cells from dominant follicles, however, at a very low concentration. The ratio CYP19P1/ CYP19A1 of mean transcript concentrations was 0.16 and 0.016, respectively. Considering these results CYP19P1 and CYP19A1 transcripts might interfere in placental cotyledons, although the underlying mechanism remains unclear. On the other hand it is unlikely that the CYP19P1 transcript plays a major role in the regulation of CYP19A1 expression in granulosa cells of dominant follicles. Interestingly, however, in granulosa cells from pre-ovulatory follicles CYP19P1 expression is shut down, just as known from CYP19A1, as a consequence of the pre-ovulatory LH-surge [14, 8] . The apparent congruent tissue-specificity of CYP19 gene and pseudogene could be explained by promoter conservation. A genomic DNA sequence covering the entire CYP19A1 and CYP19P1 loci is present in the database [GenBank:NW_003104282]. We defined the genomic sequence immediately upstream of the transcribed CYP19P1 sequence as potential pseudogene promoter and compared it with promoters of CYP19A1 by BLAST analysis. Thereby we found, that 483 bp of the proximal CYP19A1 promoter 2 ([15]; [GenBank:Z69242]) were duplicated during pseudogene genesis ( Figure 2 ). We have verified the sequence by sequencing cloned PCR products (data not shown). Gene and pseudogene promoters exhibit 83% sequence identity. Although binding motifs of GATA and SF1 transcription factors are retained, the putative pseudogene promoter has lost the functional TATA box, which might explain the low promoter activity and the use of an alternative transcription start site.
